Let-7i-3p inhibits the cell cycle, proliferation, invasion, and migration of colorectal cancer cells via downregulating CCND1.

IF 1.6
Open medicine (Warsaw, Poland) Pub Date : 2022-06-07 eCollection Date: 2022-01-01 DOI:10.1515/med-2022-0499
Fei Tu, Mengfan Li, Yinyu Chen, Huiru Chu, Shujie Wang, Lun Hai, Ting Xie, Fangfang Geng, Tiesuo Zhao, Qingzhi Wang, Zhiwei Feng
{"title":"Let-7i-3p inhibits the cell cycle, proliferation, invasion, and migration of colorectal cancer cells via downregulating CCND1.","authors":"Fei Tu,&nbsp;Mengfan Li,&nbsp;Yinyu Chen,&nbsp;Huiru Chu,&nbsp;Shujie Wang,&nbsp;Lun Hai,&nbsp;Ting Xie,&nbsp;Fangfang Geng,&nbsp;Tiesuo Zhao,&nbsp;Qingzhi Wang,&nbsp;Zhiwei Feng","doi":"10.1515/med-2022-0499","DOIUrl":null,"url":null,"abstract":"<p><p>Dysregulated microRNAs are closely related to the malignant progression of colorectal cancer (CRC). Although abnormal let-7i-3p expression has been reported in various human cancers, its biological role and potential mechanism in CRC remain unclear. Therefore, the purpose of this study was to investigate the expression and regulation of let-7i-3p in CRC. Here, we demonstrated that let-7i-3p expression was significantly downregulated in three CRC cell lines while CyclinD1 (CCND1) was upregulated compared with the normal colon epithelial FHC cells. Moreover, bioinformatics and luciferase reporter assays revealed that CCND1 was a direct functional target of let-7i-3p. In addition, let-7i-3p overexpression or CCND1 silencing inhibited cell cycle, proliferation, invasion, and migration and diminished the activation of p-ERK in HCT116 cells. However, exogenously expressing CCND1 alleviated these effects. Taken together, our findings may provide new insight into the pathogenesis of CRC and let-7i-3p/CCND1 might function as new therapeutic targets for CRC.</p>","PeriodicalId":520729,"journal":{"name":"Open medicine (Warsaw, Poland)","volume":" ","pages":"1019-1030"},"PeriodicalIF":1.6000,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175015/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open medicine (Warsaw, Poland)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1515/med-2022-0499","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Dysregulated microRNAs are closely related to the malignant progression of colorectal cancer (CRC). Although abnormal let-7i-3p expression has been reported in various human cancers, its biological role and potential mechanism in CRC remain unclear. Therefore, the purpose of this study was to investigate the expression and regulation of let-7i-3p in CRC. Here, we demonstrated that let-7i-3p expression was significantly downregulated in three CRC cell lines while CyclinD1 (CCND1) was upregulated compared with the normal colon epithelial FHC cells. Moreover, bioinformatics and luciferase reporter assays revealed that CCND1 was a direct functional target of let-7i-3p. In addition, let-7i-3p overexpression or CCND1 silencing inhibited cell cycle, proliferation, invasion, and migration and diminished the activation of p-ERK in HCT116 cells. However, exogenously expressing CCND1 alleviated these effects. Taken together, our findings may provide new insight into the pathogenesis of CRC and let-7i-3p/CCND1 might function as new therapeutic targets for CRC.

Abstract Image

Abstract Image

Abstract Image

Let-7i-3p通过下调CCND1抑制结直肠癌细胞的细胞周期、增殖、侵袭和迁移。
microrna的失调与结直肠癌(CRC)的恶性进展密切相关。尽管在多种人类癌症中已经报道了let-7i-3p的异常表达,但其在结直肠癌中的生物学作用和潜在机制尚不清楚。因此,本研究的目的是探讨let-7i-3p在CRC中的表达和调控。在这里,我们证明了let-7i-3p的表达在三种CRC细胞系中显著下调,而CyclinD1 (CCND1)的表达与正常结肠上皮FHC细胞相比上调。此外,生物信息学和荧光素酶报告基因分析显示,CCND1是let-7i-3p的直接功能靶点。此外,let-7i-3p过表达或CCND1沉默可抑制HCT116细胞的细胞周期、增殖、侵袭和迁移,并降低p-ERK的激活。然而,外源表达CCND1减轻了这些影响。综上所述,我们的研究结果可能为CRC的发病机制提供新的见解,let-7i-3p/CCND1可能成为CRC的新治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书